Literature DB >> 9518281

Human exposure to Brucella abortus strain RB51--Kansas, 1997.

.   

Abstract

On May 26-27, 1997, nine persons (a farmer, four veterinary clinicians, and four veterinary students) in Manhattan, Kansas, participated in an attempted vaginal delivery, a cesarean delivery, and a necropsy on a stillborn calf that died because of Brucella abortus infection. The infection was confirmed by isolation of B. abortus from placental and fetal lung tissue cultures. The National Animal Disease Center, U.S. Department of Agriculture (USDA), identified the B. abortus isolate from the calf as the RB51 vaccine strain. RB51 is a live, attenuated strain that was licensed conditionally by the Veterinary Services, Animal and Plant Health Inspection Service, USDA, on February 23, 1996, for vaccination of cattle in the United States. Before 1996, vaccine was made by using the S19 strain. This report describes occupational exposure to animals infected with the RB51 strain and emphasizes the need for surveillance of unintentional exposure of humans to RB51 to assess outcomes of such exposures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518281

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle.

Authors:  F A Uza; L Samartino; G Schurig; A Carrasco; K Nielsen; R F Cabrera; H R Taddeo
Journal:  Vet Res Commun       Date:  2000-04       Impact factor: 2.459

2.  Rapid and reliable single nucleotide polymorphism-based differentiation of Brucella live vaccine strains from field strains.

Authors:  Krishna K Gopaul; Jessica Sells; Betsy J Bricker; Oswald R Crasta; Adrian M Whatmore
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

3.  Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.

Authors:  R Adone; F Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

5.  Laboratory-acquired brucellosis.

Authors:  Stephanie Noviello; Richard Gallo; Molly Kelly; Ronald J Limberger; Karen DeAngelis; Louise Cain; Barbara Wallace; Nellie Dumas
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

Review 6.  Zoonoses in Veterinary Students: A Systematic Review of the Literature.

Authors:  Antonio Sánchez; Miranda Prats-van der Ham; Juan Tatay-Dualde; Ana Paterna; Christian de la Fe; Ángel Gómez-Martín; Juan C Corrales; Antonio Contreras
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

7.  Brucella Lipopolysaccharide and pathogenicity: The core of the matter.

Authors:  Judith A Smith
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

8.  Pancytopenia revealing acute brucellosis.

Authors:  Yassine Ben Lahlou; Elmostafa Benaissa; Adil Maleb; Mariama Chadli; Mostafa Elouennass
Journal:  IDCases       Date:  2020-12-29

Review 9.  Vaccine Preventable Zoonotic Diseases: Challenges and Opportunities for Public Health Progress.

Authors:  Ann Carpenter; Michelle A Waltenburg; Aron Hall; James Kile; Marie Killerby; Barbara Knust; Maria Negron; Megin Nichols; Ryan M Wallace; Casey Barton Behravesh; Jennifer H McQuiston
Journal:  Vaccines (Basel)       Date:  2022-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.